Navigation Links
Lung Cancer May Be Deadlier for Men
Date:11/13/2008

Gender is the major socioeconomic factor influencing outcomes, study finds

THURSDAY, Nov. 13 (HealthDay News) -- Men are more likely to die from inoperable non-small cell lung cancer than women, U.S. researchers report.

In fact, gender is the most important factor influencing overall survival of patients with this disease, the new study found.

A team of researchers in six U.S. cities studied 1,365 patients enrolled in national group trials to determine the effect of such sociodemographic factors as gender, race and marital status on lung cancer outcomes.

They found that men had a 1.23 times higher death rate than women, while race and marital status didn't significantly affect outcomes.

"Our study corroborates the fact that gender plays an important role as a prognostic factor in people diagnosed with lung cancer," the lead author, Dr. Benjamin Movsas, chair of the radiation oncology department at Henry Ford Hospital in Detroit, said in a news release. "This underscores the importance of studying this disease entity in light of the fact that women diagnosed with lung cancer tend to have a better outcome in terms of survival."

The study was to be presented Thursday at the Chicago Multidisciplinary Symposium in Thoracic Oncology.

At the same meeting, another group of U.S. researchers, from the South West Oncology Group, reported that a combination of traditional chemotherapy with targeted therapies called monoclonal antibodies was safe and improved survival of patients with advanced non-small cell lung cancer.

The study found that the use of two targeted therapies (bevacizumab and cetuximab) with chemotherapy (carboplatin and paclitaxel) as first-line treatment improved the survival of 104 patients who were evaluated between August 2006 and September 2007. There were no safety concerns.

"The combination of multiple targeted therapies in addition to chemotherapy may be the future of treatment in lung cancer," lead author Dr. Edward Kim, an assistant professor in the department of thoracic/head and neck medical oncology at M.D. Anderson Cancer Center in Houston, said in a news release. "Blocking more key cancer pathways such as the epidermal growth factor receptor and vascular endothelial growth factor may lead to improved cancer control."

In 2008, about 215,000 new cases of lung cancer will be diagnosed in the United States and 161,840 people will die from the disease, according to the U.S. National Cancer Institute.

More information

The American Cancer Society has more about non-small cell lung cancer.



-- Robert Preidt



SOURCE: American Society for Therapeutic Radiology and Oncology, news releases, Nov. 13, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer treatment may result in bone loss
2. American Academy of Dermatology: Stop Skin Cancer On The Spot
3. Gender is key factor in determining overall survival of lung cancer patients
4. Proton therapy may reduce serious side effect of lung cancer treatment
5. Tissue analyses indicate survival benefits for some lung cancer patients
6. Advanced lung cancer patients see improved, progression-free survival
7. Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
8. Research demonstrates differing genetic makeup of lung cancer in African-American patients
9. Novel 4-drug combination proves safe for lung cancer treatment
10. US Oncology Applauds Senator Baucuss Healthcare Reform Call to Action for 2009, Supports Collaborative Measures to Enhance Cancer Patients Access to Care While Improving Quality and Access
11. AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung Cancer May Be Deadlier for Men
(Date:9/20/2017)... Raton (PRWEB) , ... September 20, 2017 , ... In ... Daily Brain Booster has already been receiving positive feedback from customers trying the product ... months. , Daily Brain Booster was developed by neurosurgeon Shawn Moore, MD, for ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... of older Americans at risk of price gouging for their prescription drugs, according ... (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency in ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION” is the creation of published ... the field of addiction and homeless services, including more than a decade of ...
(Date:9/20/2017)... ... ... “Psalms of Humidity”: is a fascinating depiction of daily struggles and the ... closer to God. “Psalms of Humidity” is the creation of published author, David Waldrop, ... his life are the very same things that have shaped him into the man ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... nearly two decades, New Life Agency has been committed to providing the ... Life Agency announces a powerful three-way partnership designed to deliver substantial savings ... ... http://www.schrafts2.com/ (PRNewsfoto/PharmaCareCard) ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/6/2017)... SAN ANTONIO , Sept. 6, 2017  Robert ... as a Pinnacle Professional Member in recognition of his ... Dr. Szewc serves as a Nephrologist at the practice ... services, emergency medicine, kidney care and hypertension solutions. He ... over 20 years of career experience, as well as ...
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
Breaking Medicine Technology: